Hyperhomocysteinemia as a component of syndrome X.

[1]  P. Ducimetiere,et al.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population , 1980, Diabetologia.

[2]  H. Canatan,et al.  Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats. , 2002, Archives of medical research.

[3]  R. Goberna,et al.  Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. , 2002, The Journal of nutritional biochemistry.

[4]  P. Mueller,et al.  Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. , 2002, International journal of epidemiology.

[5]  J. Racek,et al.  Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. , 2002, Physiological Research.

[6]  K. U. Lee,et al.  Oxidative stress markers in Korean subjects with insulin resistance syndrome. , 2001, Diabetes Research and Clinical Practice.

[7]  G. Brocco,et al.  Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women. , 2001, Diabetes, nutrition & metabolism.

[8]  L. Fink,et al.  The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes. , 2001, Atherosclerosis.

[9]  D. Singer,et al.  Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. , 2001, Diabetes care.

[10]  T. Shoji,et al.  Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. , 2001, Diabetes care.

[11]  I. Godsland,et al.  Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. , 2001, The Journal of clinical endocrinology and metabolism.

[12]  H. Mangge,et al.  Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. , 2000, Diabetes care.

[13]  L. Fink,et al.  Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. , 2000, Metabolism: clinical and experimental.

[14]  S. Yusuf,et al.  Homocyst(e)ine and Cardiovascular Disease , 2000 .

[15]  W. Sheu,et al.  Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. , 2000, The American journal of the medical sciences.

[16]  W. Sheu,et al.  Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. , 2000, American journal of hypertension.

[17]  M. Hanefeld,et al.  Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism , 2000, Amino Acids.

[18]  G. Reaven,et al.  Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. , 1999, Atherosclerosis.

[19]  M. Brosnan,et al.  Regulation of homocysteine metabolism. , 1999, Advances in enzyme regulation.

[20]  D. Sprecher.  Triglycerides as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[21]  M. Brosnan,et al.  Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. , 1998, Diabetes.

[22]  A. Gotto.  Triglyceride as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[23]  C. Cronin,et al.  Plasma homocysteine concentrations in patients with type 1 diabetes. , 1998, Diabetes care.

[24]  M. Laakso,et al.  Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 1998, Circulation.

[25]  E. Giltay,et al.  Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. , 1998, Atherosclerosis.

[26]  S. Mudaliar,et al.  Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. , 1998, Metabolism: clinical and experimental.

[27]  M. Law,et al.  Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. , 1998, Archives of internal medicine.

[28]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[29]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[30]  J. Witteman,et al.  Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[31]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[32]  S. Ebrahim,et al.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.

[33]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[34]  K. Bønaa,et al.  Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.

[35]  G. Lip,et al.  Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians , 1995, British heart journal.

[36]  C. Bray,et al.  Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? , 1994, British heart journal.

[37]  D. Jullien,et al.  Type 1 diabetes mellitus and homocyst(e)ine. , 1994, Diabete & metabolisme.

[38]  M. Secic,et al.  Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. , 1994, Clinical chemistry.

[39]  G. Reaven.  Syndrome X: 6 years later. , 1994, Journal of internal medicine. Supplement.

[40]  M. Blankenstein,et al.  The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. , 1993, Metabolism: clinical and experimental.

[41]  E. Bonora,et al.  Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia , 1993, Journal of internal medicine.

[42]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[43]  G. Reaven,et al.  Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. , 1991, JAMA.

[44]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[45]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[46]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[47]  B. Israelsson,et al.  Homocysteine and myocardial infarction. , 1988, Atherosclerosis.

[48]  G. Reaven,et al.  Mechanism of insulin resistance in fructose-fed rats. , 1982, Metabolism: clinical and experimental.